Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three-year Recurrence Free Survival in Patients With Ultra-low-risk Endometrial Cancer Who do Not Undergo Lymph Node dissEction

NCT04227249 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04227249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three-year Recurrence Free Survival in Patients With Ultra-low-risk Endometrial Cancer Who do Not Undergo Lymph Node dissEction
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2020
Completion date
March 31, 2027
Enrollment
153 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer